EquityZen Growth Technology Fund LLC - Series 1799
Raised
$114K
Investors
7
Min Invest
$10,004
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1799 is a Delaware-based pooled investment fund filed by EquityZen Advisors LLC and Phil Haslett. The fund raised $114K from 7 investors with a $10K minimum investment, operating under Rule 506(b) and Section 3(c)(1) exemptions. This is part of EquityZen's pre-IPO investment platform, which has filed over 1,800 related entities.
This pre-IPO pooled investment fund operates under the standard 506(b) private placement exemption paired with 3(c)(1) Investment Company Act exclusion. The $10K minimum investment represents a retail-accessible tier within the pre-IPO category, significantly lower than typical institutional pre-IPO vehicles which often require $100K+ minimums.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Phil Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
